Omid Shah, MD
Assistant Professor
Medicine
School of Medicine

Omid Shah is an Assistant Clinical Professor of Medicine at the University of California, San Francisco (UCSF). He cares for patients on the inpatient medicine direct care and teaching services at Moffit-Long Hospital and St Mary's Medical Center, San Francisco. In addition, he provides inpatient medicine consultation services at UCSF's Mission Bay Hospital.

Show full bio (110 words) Hide full bio

Dr. Shah's clinical experiences span just over a decade and two continents having trained and practiced in the UK before moving to the US to complete his training in internal medicine at Columbia University Vagelos College of Physicians and Surgeons affiliate program at Mary Imogene Bassett Hospital in Cooperstown, NY.

Dr Shah is committed to contributing meaningfully to the field of hospital medicine by applying both his clinical experiences and his academic skills gained from the 3 years he spent as a clinical translational research associate at Stanford to his academic interests: quality improvement, medical education and diversity, equity and inclusion.

Awards

Show all (1) Hide

• SOAMS Scholarship (Sheffield Outreach and Access to Medical Scheme), University of Sheffield, 2004

Education & Training

Show all (6) Hide

• Chief Resident Internal Medicine Mary Imogene Bassett Hospital (Columbia School of Physicians & Surgeons Affiliate) 06/2021
• Residency Internal Medicine Mary Imogene Bassett Hospital (Columbia School of Physicians & Surgeons Affiliate) 06/2021
• Clinical Translational Research Associate Immunology/BMT Stanford School of Medicine 06/2018
• Specialty Training Neurosurgery University Hospitals Birmingham 11/2014
• House Officer Medicine and Surgery Sheffield Teaching Hospitals 08/2011
• MD University of Sheffield 06/2009

Interests

Show all (8) Hide

• Quality Improvement
• Medical Education
• Hospital Medicine
• Diversity
• Equity and Inclusion
• Evidence Based Medicine
• Bedside clinical exam
• Healthcare data analytics

Publications (9)

Top publication keywords:
Graft vs Host DiseaseInterferon Regulatory Factor-7Hematologic NeoplasmsReceptors, Antigen, T-CellActivating Transcription Factor 4fms-Like Tyrosine Kinase 3Clonal EvolutionHematoma, Subdural, AcuteMyeloproliferative DisordersInterleukin-15Hematopoietic Stem Cell TransplantationIntracranial HypertensionDecompressive CraniectomyCytokine-Induced Killer CellsClone Cells

• Is this heart failure?
  Emergency medicine journal : EMJ 2022 Thangjui S, Shah O, Zoltick J
• Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2020 Shah O, Tamaresis JS, Kenyon LJ, Xu L, Zheng P, Gupta P, Rangarajan K, Lee S, Spellman S, Nikiforow S, Zehnder J, Meyer EH
• Clonal Evolution and Changes in Two AML Patients Detected with A Novel Single-Cell DNA Sequencing Platform.
  Scientific reports 2019 Xu L, Durruthy-Durruthy R, Eastburn DJ, Pellegrino M, Shah O, Meyer E, Zehnder J
• Efficacy of Pembrolizumab and Nivolumab in Crossing the Blood Brain Barrier.
  Cureus 2019 Abid H, Watthanasuntorn K, Shah O, Gnanajothy R
• Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 Narayan R, Benjamin JE, Shah O, Tian L, Tate K, Armstrong R, Xie BJ, Lowsky R, Laport G, Negrin RS, Meyer EH

Show all (4 more) Hide

• Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
  Nature medicine 2018 Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Müller TA, Hanke K, Taromi S, Apostolova P, Illert AL, Melchinger W, Duquesne S, Schmitt-Graeff A, Osswald L, Yan KL, Weber A, …
• Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
  Nature medicine 2018 Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Müller TA, Hanke K, Taromi S, Apostolova P, Illert AL, Melchinger W, Duquesne S, Schmitt-Graeff A, Osswald L, Yan KL, Weber A, …
• Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.
  International journal of radiation oncology, biology, physics 2017 Baird JR, Monjazeb AM, Shah O, McGee H, Murphy WJ, Crittenden MR, Gough MJ
• Surgery for Acute Subdural Hematoma: Replace or Remove the Bone Flap?
  World neurosurgery 2015 Tsermoulas G, Shah O, Wijesinghe HE, Silva AHD, Ramalingam SK, Belli A